Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral

The heterogeneous nature of osteoarthritis (OA) and the need to subtype patients is widely accepted in the field. The biomarker CRPM, a metabolite of C-reactive protein (CRP), is released to the circulation during inflammation. Blood CRPM levels have shown to be associated with disease activity and response to treatment in rheumatoid arthritis (RA). We investigated the level of blood CRPM in OA compared to RA using data from two phase III knee OA and two RA studies (N = 1591). Moreover, the association between CRPM levels and radiographic progression was investigated. The mean CRPM levels were significantly lower in OA (8.5 [95% CI 8.3–8.8] ng/mL, n = 781) compared to the RA patients (12.8 [9.5–16.0] ng/mL, n = 60); however, a significant subset of OA patients (31%) had CRPM levels (≥ 9 ng/mL) comparable to RA.


Fig: Baseline serum CRP and CRPM levels in early arthritis (E-RA), moderate to severe RA (MS-RA) and osteoarthritis (OA) patients compared to early RA patients. (A) Serum CRP levels and (B) serum CRPM levels. Grey vertical bars indicate the normal references ranges established in the central lab measuring the markers. Data are shown as IQR and differences are tested by ANCOVA using log transformed biomarker data adjusting for covariates (age, gender, race, VAS pain). Bonferroni corrected significance levels: **p < 0.01 and ****p < 0.0001.

Furthermore, OA patients (n = 152) with CRPM levels ≥ 9 ng/mL were more likely to develop contra-lateral knee OA assessed by X-ray over a two-year follow-up period with an odds ratio of 2.2 [1.0–4.7]. These data suggest that CRPM is a blood-based biochemical marker for early identification OA patients with an inflammatory phenotype.

Bay-Jensen, AC., Bihlet, A., Byrjalsen, I. et al. Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral knee osteoarthritis. Sci Rep 11, 6583 (2021).

Leave a Reply

Your email address will not be published. Required fields are marked *